MoonLake ImmunotherapeuticsMLTXNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+55.0%
5Y CAGR+369.9%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+55.0%/yr
Annual compound
5Y CAGR
+369.9%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
2290.4x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $242.22M | +69.3% |
| 2024 | $143.09M | +164.4% |
| 2023 | $54.12M | -16.8% |
| 2022 | $65.06M | +21.4% |
| 2021 | $53.57M | +50556.7% |
| 2020 | $105755.00 | - |